Department of Surgery, 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China.
Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11323-11333. doi: 10.26355/eurrev_202011_23623.
Traditional anti-cancer treatments are far from satisfactory. There is an urgent to combine new therapeutics with traditional treatments to improve anti-cancer effectiveness. Ferroptosis is a new type of iron dependent non-apoptotic cell death could still offer benefits to patients who failed in apoptosis and necroptosis induction treatment. Iron plays a vital role during ferroptosis induction. While iron is a double-edged sword in cancer treatment, tumor specific distribution of iron is especially important. Nanotechnology is an efficient way to help drugs targeting distribution. We intended to review the latest progress in ferroptosis and iron based nanotherapeutics. First, the relationship between ferroptosis and iron metabolism was reviewed briefly to demonstrate the central role of iron in ferroptosis induction. Second, the latest progress of iron-based nanotechnology was presented and discussed according to the different designs. Finally, the future expectations of iron based nanotherapeutics for ferroptosis were spotlighted.
传统的抗癌治疗方法远不能令人满意。迫切需要将新的治疗方法与传统治疗方法相结合,以提高抗癌效果。铁死亡是一种新型的铁依赖性非凋亡细胞死亡方式,对于那些在凋亡和坏死诱导治疗中失败的患者仍然有好处。铁在铁死亡诱导中起着至关重要的作用。虽然铁在癌症治疗中是一把双刃剑,但肿瘤中铁的特异性分布尤为重要。纳米技术是一种帮助药物靶向分布的有效方法。我们旨在综述铁死亡和基于铁的纳米治疗学的最新进展。首先,简要回顾了铁死亡与铁代谢之间的关系,以证明铁在铁死亡诱导中的核心作用。其次,根据不同的设计介绍和讨论了基于铁的纳米技术的最新进展。最后,重点介绍了基于铁的纳米治疗学在铁死亡方面的未来期望。